Israeli company uses placenta cells to treat critical COVID-19 patientsThe company dosed three patients in two different hospitals in Israel under a compassionate use program for the treatment of COVID-19.Biologists work in a laboratory at Pluristem Therapeutics Inc. in Haifa(photo credit: BAZ RATNER/REUTERS)
